Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Rodenhuis

Showing results (21-30 of 150) with videos related to

Pageof 15
Sort By:
Thorax|February 1, 1992
Invasive aspergillosis complicated by subclavian artery occlusion and costal osteomyelitis after autologous bone marrow transplantationL T Vlasveld, J F Delemarre, J H Beynen, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Intraperitoneal chemotherapy for malignant peritoneal mesotheliomaL T Vlasveld, M P Gallee, S Rodenhuis, et al.
Leukemia|February 1, 1987
Effects of methotrexate and of the "nonclassical" folate antagonist trimetrexate on human leukemia cellsS Rodenhuis, J J McGuire, W L Sawicki, et al.
Anti-Cancer Drugs|July 19, 2001
Urinary excretion of thioTEPA and its metabolites in patients treated with high-dose cyclophosphamide, thioTEPA and carboplatinM J van Maanen, A D Huitema, S Rodenhuis, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|June 22, 2001
Sensitive gas chromatographic determination of the cyclophosphamide metabolite 2-dechloroethylcyclophosphamide in human plasmaA D Huitema, C Reinders, M M Tibben, et al.
Therapeutic Drug Monitoring|March 2, 1999
Sampling technique from central venous catheters proves critical for pharmacokinetic studiesA D Huitema, M Holtkamp, M M Tibben, et al.
Vox Sanguinis|January 1, 1985
Inefficacy of plasma exchange in cold agglutinin hemolytic anemia--a case studyS Rodenhuis, A Maas, C A Hazenberg, et al.
European Journal of Cancer (Oxford, England : 1990)|August 1, 1997
Docetaxel alternating with epirubicin and cyclophosphamide: a feasibility study in breast cancer patientsW W ten Bokkel Huinink, V Lustig, R Dubbelman, et al.
Cancer Chemotherapy and Pharmacology|September 6, 2000
Reduction of cyclophosphamide bioactivation by thioTEPA: critical sequence-dependency in high-dose chemotherapy regimensA D Huitema, T Kerbusch, M M Tibben, et al.
British Journal of Cancer|April 20, 2006
High exposures to bioactivated cyclophosphamide are related to the occurrence of veno-occlusive disease of the liver following high-dose chemotherapyM E de Jonge, A D R Huitema, J H Beijnen, et al.
Pageof 15

Showing results (21-30 of 150) with videos related to

Sort By:
Pageof 15
Thorax|February 1, 1992
Invasive aspergillosis complicated by subclavian artery occlusion and costal osteomyelitis after autologous bone marrow transplantationL T Vlasveld, J F Delemarre, J H Beynen, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Intraperitoneal chemotherapy for malignant peritoneal mesotheliomaL T Vlasveld, M P Gallee, S Rodenhuis, et al.
Leukemia|February 1, 1987
Effects of methotrexate and of the "nonclassical" folate antagonist trimetrexate on human leukemia cellsS Rodenhuis, J J McGuire, W L Sawicki, et al.
Anti-Cancer Drugs|July 19, 2001
Urinary excretion of thioTEPA and its metabolites in patients treated with high-dose cyclophosphamide, thioTEPA and carboplatinM J van Maanen, A D Huitema, S Rodenhuis, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|June 22, 2001
Sensitive gas chromatographic determination of the cyclophosphamide metabolite 2-dechloroethylcyclophosphamide in human plasmaA D Huitema, C Reinders, M M Tibben, et al.
Therapeutic Drug Monitoring|March 2, 1999
Sampling technique from central venous catheters proves critical for pharmacokinetic studiesA D Huitema, M Holtkamp, M M Tibben, et al.
Vox Sanguinis|January 1, 1985
Inefficacy of plasma exchange in cold agglutinin hemolytic anemia--a case studyS Rodenhuis, A Maas, C A Hazenberg, et al.
European Journal of Cancer (Oxford, England : 1990)|August 1, 1997
Docetaxel alternating with epirubicin and cyclophosphamide: a feasibility study in breast cancer patientsW W ten Bokkel Huinink, V Lustig, R Dubbelman, et al.
Cancer Chemotherapy and Pharmacology|September 6, 2000
Reduction of cyclophosphamide bioactivation by thioTEPA: critical sequence-dependency in high-dose chemotherapy regimensA D Huitema, T Kerbusch, M M Tibben, et al.
British Journal of Cancer|April 20, 2006
High exposures to bioactivated cyclophosphamide are related to the occurrence of veno-occlusive disease of the liver following high-dose chemotherapyM E de Jonge, A D R Huitema, J H Beijnen, et al.
Pageof 15